NCT01971632View on ClinicalTrials.gov

A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

463

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Subjects With Moderate to Severe, Chronic Nonmalignant Pain
Interventions
DRUG

Oxycodone & naloxone combination, prolonged release

DRUG

placebo oxycodone / naloxone

All Listed Sponsors
lead

Mundipharma Research GmbH & Co KG

INDUSTRY

NCT01971632 - A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain | Biotech Hunter | Biotech Hunter